Simon Heller (DM, FRCP) is Professor of Clinical Diabetes at the University of Sheffield, UK, and Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust, UK. He trained at Queen’s Medical Centre, Nottingham and undertook his research training at the University of Nottingham and Washington University, USA.
Professor Heller is currently a member of the Diabetes UK Research Strategy Group Management Group and a sub-panel chair of the UK NIHR Programme Grants for Applied Research funding scheme. He is also the National Specialty Lead in Diabetes to the UK NIHR Clinical Research Network and an NIHR Senior Investigator Emeritus.
His current research interests include the pathophysiological responses to hypoglycaemia and hypoglycaemia unawareness, the potential contribution and mechanisms of hypoglycaemia to cardiovascular mortality, the use of insulin analogues and other technologies to reduce hypoglycaemia. He chaired the glucose control group of the ADVANCE trial and was the PI on the REPOSE trial measuring the effectiveness of insulin pumps. He also conducts research programmes concerned with developing interventions (including the DAFNE intervention) to encourage more effective diabetes self-management. He chairs the International Hypoglycaemia Study Group, 15 professionals and academics with expertise in diabetic hypoglycaemia who have recently been working with both ADA and EASD to extend the classification of hypoglycaemia. He has authored over 300 original research articles and reviews. From 2000-2005 he was Editor of Diabetic Medicine.
Duality of Interest: Professor Heller has received research support/grants from Medtronic and payments for board membership/advisory panels from Zealand Pharma.
Date: Autumn 2022